NVWM LLC’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.05M | Sell |
2,367
-16
| -0.7% | -$7.12K | 0.25% | 121 |
|
|
2025
Q1 | $1.16M | Sell |
2,383
-1
| -0% | -$485 | 0.31% | 95 |
|
|
2024
Q4 | $960K | Sell |
2,384
-23
| -1% | -$9.26K | 0.24% | 126 |
|
|
2024
Q3 | $1.12M | Sell |
2,407
-10
| -0.4% | -$4.65K | 0.28% | 112 |
|
|
2024
Q2 | $1.13M | Sell |
2,417
-8
| -0.3% | -$3.75K | 0.3% | 99 |
|
|
2024
Q1 | $1.01M | Buy |
2,425
+47
| +2% | +$19.6K | 0.28% | 111 |
|
|
2023
Q4 | $968K | Sell |
2,378
-72
| -3% | -$29.3K | 0.29% | 105 |
|
|
2023
Q3 | $852K | Buy |
2,450
+9
| +0.4% | +$3.13K | 0.28% | 114 |
|
|
2023
Q2 | $859K | Buy |
2,441
+52
| +2% | +$18.3K | 0.28% | 115 |
|
|
2023
Q1 | $753K | Buy |
2,389
+250
| +12% | +$78.8K | 0.25% | 118 |
|
|
2022
Q4 | $618K | Buy |
2,139
+2,073
| +3,141% | +$599K | 0.22% | 135 |
|
|
2022
Q3 | $19K | Buy |
+66
| New | +$19K | 0.01% | 289 |
|
|
2021
Q4 | – | Sell |
-25
| Closed | -$5K | – | 549 |
|
|
2021
Q3 | $5K | Buy |
+25
| New | +$5K | ﹤0.01% | 427 |
|
|
2021
Q1 | – | Sell |
-25
| Closed | -$5K | – | 464 |
|
|
2020
Q4 | $5K | Sell |
25
-4,202
| -99% | -$840K | ﹤0.01% | 334 |
|
|
2020
Q3 | $1.15M | Buy |
4,227
+136
| +3% | +$37K | 0.54% | 53 |
|
|
2020
Q2 | $1.19M | Buy |
4,091
+12
| +0.3% | +$3.48K | 0.64% | 47 |
|
|
2020
Q1 | $971K | Buy |
4,079
+481
| +13% | +$115K | 0.67% | 40 |
|
|
2019
Q4 | $788K | Sell |
3,598
-622
| -15% | -$136K | 0.47% | 65 |
|
|
2019
Q3 | $715K | Buy |
4,220
+997
| +31% | +$169K | 0.44% | 74 |
|
|
2019
Q2 | $591K | Buy |
3,223
+146
| +5% | +$26.8K | 0.36% | 92 |
|
|
2019
Q1 | $566K | Buy |
3,077
+100
| +3% | +$18.4K | 0.38% | 92 |
|
|
2018
Q4 | $493K | Hold |
2,977
| – | – | 0.37% | 90 |
|
|
2018
Q3 | $574K | Buy |
2,977
+2,758
| +1,259% | +$532K | 0.36% | 89 |
|
|
2018
Q2 | $37K | Hold |
219
| – | – | 0.03% | 190 |
|
|
2018
Q1 | $34K | Buy |
219
+77
| +54% | +$12K | 0.02% | 203 |
|
|
2017
Q4 | $21K | Buy |
+142
| New | +$21K | 0.02% | 214 |
|